195. ヌーナン症候群 Noonan syndrome Clinical trials / Disease details

臨床試験数 : 14 / 薬物数 : 15 - (DrugBank : 5) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 9

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02713945 (ClinicalTrials.gov)	January 25, 2017	9/3/2016	Treatment With HMG-COA Reductase Inhibitor of Growth and Bone Abnormalities in Children With Noonan ...	Treatment With HMG-COA Reductase Inhibitor (Simvastatin) of Growth and Bone Abnormalities in Childre ...	Noonan Syndrome	Drug: Simvastatin;Drug: Placebo	University Hospital, Toulouse	NULL	Recruiting	6 Years	16 Years	All	62	Phase 3	France
2	EUCTR2016-000647-14-FR (EUCTR)	23/05/2016	30/03/2016	Treatment with simvastatin of growth and bone abnormalities in children with Noonan syndrome	Treatment with HMG-COA reductase inhibitor (simvastatin) of growth and bone abnormalities in childre ...	Noonan syndrome;Therapeutic area: Body processes [G] - Genetic Phenomena [G05]	Trade Name: Simvastatin Product Name: Simvastatin	University Hospital Toulouse	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	62	Phase 3	France

First Previous1Next Last